Lignans' potential in pre- and post-onset type 2 diabetes management

Current Diabetes Reviews
D E Barre, K A Mizier-Barre

Abstract

Type 2 diabetes (T2D) cases continue to rise dramatically despite efforts to get people to exercise and eat with a view to health and combatting the cluster of 7 issues (elevated waist circumference, hyperglycaemia, hypertension, dyslipidemia, pro-thrombotic state, increased oxidation (including low density lipoprotein (LDL)) and the pro-inflammatory state associated with pre- and post-onset T2D. There are numerous medications available to deal with these seven major issues. However, each medication currently available manages a maximum of two cluster members at a time. Consequently, polypharmacy is frequently required to manage the cluster of seven. Polypharmacy brings with it high financial costs for numerous medications, the risk of poor compliance (particularly so in older patients), side effects and drug interactions. Thus, there is a search for new agents that reduce the high costs and risks of polypharmacy while at the same time combatting three or more of the cluster of seven. There is very limited evidence to suggest that one or more lignans may efficaciously and safely, in the short and long term, manage at least three of the cluster of seven, pre- and post-T2D onset, thus reducing polypharmacy. However, multi-centre,...Continue Reading

References

Apr 14, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·C BannwartT Hase
Apr 26, 1996·Atherosclerosis·F HirataH Nakamura
Dec 20, 1999·Journal of Agricultural and Food Chemistry·L P MeagherB W Li
Nov 4, 2000·The International Journal of Angiology : Official Publication of the International College of Angiology, Inc·K Prasad
Jul 4, 2001·The Journal of Laboratory and Clinical Medicine·K Prasad
Oct 12, 2001·The American Journal of Cardiology·D W Erkelens
Jan 5, 2002·Diabetes Care·Nick A RoperUNKNOWN South Tees Diabetes Mortality Study
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
May 22, 2002·JAMA : the Journal of the American Medical Association·Joshua A BeckmanPeter Libby
Jun 4, 2002·European Heart Journal·A D Pradhan, P M Ridker
Aug 13, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Yvonne T van der SchouwDiederick E Grobbee
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Kyoko NishiShinji Nagahiro
Mar 13, 2003·Kidney International·William F KeaneUNKNOWN RENAAL Study Investigators
Mar 26, 2003·Journal of the American College of Cardiology·Paolo GreseleGeremia B Bolli
Apr 30, 2003·The American Journal of Clinical Nutrition·Marieke B SnijderJacob C Seidell
Apr 30, 2003·Diabetes Care·Richard W GrantJames B Meigs
Jun 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Seiichi KobayashiMitsuhiro Yokoyama
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliCarmine Zoccali
May 27, 2004·Diabetes Care·Ronald M Krauss
Jun 18, 2004·Journal of Hypertension·Sanne Kreijkamp-KaspersYvonne T van der Schouw
Dec 9, 2004·Atherosclerosis·Sanne Kreijkamp-KaspersYvonne T van der Schouw
Feb 3, 2005·Obesity Research·F Xavier Pi-Sunyer
Jan 25, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Susanne B SchwedlerLawrence A Potempa
Feb 24, 2006·International Journal of Clinical Practice·E WrightL C Glass
Mar 21, 2006·Journal of the American College of Cardiology·Scott M Grundy
Jun 6, 2006·Phytotherapy Research : PTR·Senugmi YangJong Seog Ahn
Aug 11, 2006·Nutrition and Cancer·Lilian U ThompsonNancy Kreiger
Dec 15, 2006·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Karim Zouaoui BoudjeltiaDany Brohee
Apr 19, 2007·American Journal of Physiology. Endocrinology and Metabolism·Koichiro AzumaUNKNOWN Look AHEAD Adipose Research Group

❮ Previous
Next ❯

Citations

Dec 14, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alessandra DurazzoLuisa Marletta

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.